Viewing Study NCT01724294


Ignite Creation Date: 2025-12-25 @ 1:43 AM
Ignite Modification Date: 2025-12-26 @ 12:01 AM
Study NCT ID: NCT01724294
Status: TERMINATED
Last Update Posted: 2016-11-02
First Post: 2012-11-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Observational Study of MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in First-Line in Patients With Diffuse Large B-Cell Lymphoma
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module